Novo Nordisk

+$0.37 (+0.40%) As of 7:20 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals.

CEO
Lars Fruergaard Jørgensen
Employees
45,323
Headquarters
Bagsværd, Capital Region
Founded
1925

NVO Key Statistics

Market Cap
192.95B
Price-Earnings Ratio
32.00
Dividend Yield
1.11
Average Volume
1.15M
High Today
$92.99
Low Today
$91.67
Open Price
$92.19
Volume
578.13K
52 Week High
$92.99
52 Week Low
$63.22

NVO News

Los Angeles TimesJul 29

A diabetes drug’s new weight management formula comes with a big price

Ads for the latest drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people —

NVO Earnings

$0.00
$0.29
$0.59
$0.88
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure